Omni-Protech Drugs Private Limited, a active private limited company, was established on 12 March 1993 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239PN1993PTC071120. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.50 M.
It upholds a compliant status. Employing 84 professional, Its leadership includes Atharva Brijmohan Sharma (Director), Bipin Vasantrao Katdare (Whole-Time Director), Brijmohan Sharma (Director). Past directors included Atharva Brijmohan Sharma, Vilas Shankar Indalkar, Bipin Vasantrao Katdare. It holds ₹56.60 Cr open charges and ₹11.20 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.C-4-13 Midc Functionalelectronics Indl.Estate Bhosar, I, Pune, Maharashtra, 411026.
U24239PN1993PTC071120
071120
12 March 1993
₹5.00 M
₹4.50 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Omni-Protech Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atharva Brijmohan Sharma | Director | 26 Feb 2024 | Current |
| Bipin Vasantrao Katdare | Whole-Time Director | 30 Dec 2008 | Current |
| Brijmohan Sharma | Director | 20 Jul 2003 | Current |
| Eshan Brijmohan Sharma | Director | 03 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Nov 2023 | Past |
| Pramod Abcsdd | Director | 27 Apr 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 27 Dec 2008 | Past |
| Pramod Abcsdd | Director | 31 Oct 2011 | Past |
| Pramod Abcsdd | Director | 27 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omni-Protech Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.38% decrease. The company also saw a substantial fall in profitability, with a 43.62% decrease in profit. The company's net worth moved up by a moderate rise of 9.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Omni-Protech Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹565,970,516.00
₹112,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 2025 | Hdfc Bank Limited | ₹2.10 Cr | Open |
| 06 Nov 2024 | Axis Bank Limited | ₹20.00 Cr | Open |
| 04 Jun 2024 | Axis Bank Limited | ₹20.15 Cr | Open |
| 23 Feb 2024 | Hdfc Bank Limited | ₹4.85 Cr | Open |
| 14 Aug 1997 | Bnp Paribas | ₹9.50 Cr | Open |
Explore comprehensive loan charge details -
Omni-Protech Drugs has a workforce of 84 employees as of Dec 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Omni-Protech Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omni-Protech Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 21.00 M with Charge ID 101095642 was registered on 24 Apr 2025. was documented.
The activity Eshan Brijmohan Sharma was appointed as a Director was appointed as a Director on 03 Apr 2025 & has been associated with this company since 7 months 25 days . was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 200.00 M with Charge ID 101045365 was registered on 06 Nov 2024. was completed.
Progress on Omni-Protech Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Hdfc Bank Limited of Rs. 48.50 M registered on 23 Feb 2024 with Charge ID 100886251 was modified on 19 Jul 2024. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 201.47 M with Charge ID 100949737 was registered on 04 Jun 2024. was completed.
The CIN of Omni-Protech Drugs Private Limited is U24239PN1993PTC071120.
Omni-Protech Drugs Private Limited is headquartered at Plot No.C-4-13 Midc Functionalelectronics Indl.Estate Bhosar, I, Pune, Maharashtra, 411026.
Omni-Protech Drugs Private Limited was incorporated on 12 March 1993.
The current directors of Omni-Protech Drugs Private Limited are
The primary industry of Omni-Protech Drugs Private Limited is Manufacturing.
Omni-Protech Drugs Private Limited is unlisted.
The authorized capital of Omni-Protech Drugs Private Limited is ₹5.00 M, and the paid-up capital is ₹4.50 M.
The compliance status of Omni-Protech Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX